Helena Jernström
21 – 30 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
(
- Contribution to journal › Article
- 2019
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Patients' and physicians' disagreement on patients' understanding of clinical cancer trial information : A pairwise pilot study of mirroring subjective assessments compared with objective measurements
(
- Contribution to journal › Article
- 2018
-
Mark
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
(
- Contribution to journal › Article
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
(
- Contribution to journal › Article
-
Mark
Patients' reasoning regarding the decision to participate in clinical cancer trials : an interview study
(
- Contribution to journal › Article
-
Mark
Increasing preoperative body size in breast cancer patients between 2002 and 2016 : implications for prognosis
(
- Contribution to journal › Article